Stay updated on AGN-241751 Efficacy in Major Depression Clinical Trial
Sign up to get notified when there's something new on the AGN-241751 Efficacy in Major Depression Clinical Trial page.

Latest updates to the AGN-241751 Efficacy in Major Depression Clinical Trial page
- CheckyesterdayChange DetectedThe record shows the study title updated to Zelquistinel in the Treatment of Adults With Major Depressive Disorder (AGN-241751) and the addition of Study Status and Study Identification sections, replacing the prior title AGN-241751 in the Treatment of Major Depressive Disorder.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check30 days agoChange DetectedThe Record History now lists Revision: v3.4.3 and removes the previous Revision: v3.4.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe latest version updates the Record History with new entries showing changes to study status and related fields such as eligibility and locations.SummaryDifference0.1%

- Check58 days agoChange DetectedNew revision entry v3.4.2 was added and older notices (government funding lapse message and v3.4.1) were removed; these are administrative changes that do not affect trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check65 days agoChange DetectedA new site-wide notice about government funding status appears, and the revision entry changes from v3.4.0 to v3.4.1.SummaryDifference0.7%

Stay in the know with updates to AGN-241751 Efficacy in Major Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGN-241751 Efficacy in Major Depression Clinical Trial page.